Effects of glycemic indicators on early neurological outcomes in patients with acute ischemic stroke treated with intravenous thrombolysis

Table 3 Multivariate analysis of the associations between glycemic indicators and early neurological outcomes in the whole population

Parameter	Early neurological deterioration			Early neurological improvement
	OR	95%CI	P value	OR	95%CI	P value
Admission hyperglycemia	1.744	1.236-2.463	0.002	0.928	0.622-1.383	0.712
Fasting blood glucose
First quartile	Reference	Reference	Reference	Reference	Reference	Reference
Second quartile	1.259	0.739-2.146	0.396	0.724	0.439-1.195	0.207
Third quartile	1.746	1.045-2.917	0.033	0.789	0.471-1.321	0.367
Fourth quartile	2.436	1.476-4.022	0.001	0.713	0.413-1.230	0.224
Stress hyperglycemia ratio
First quartile	Reference	Reference	Reference	Reference	Reference	Reference
Second quartile	2.306	1.342-3.960	0.002	1.875	0.976-2.321	0.067
Third quartile	2.284	1.346-3.876	0.002	1.059	0.618-1.816	0.834
Fourth quartile	3.486	2.088-5.820	0.001	1.293	0.736-2.274	0.372

Neither early neurological improvement nor early neurological deterioration group was the reference group. Adjustment by age, sex, blood pressure, atrial fibrillation, initial National Institutes of Health Stroke Scale, stroke subtype and systolic blood pressure. CI: Confidence interval; OR: Odds ratio.